check out one month chart- im a buyer
You need to do the DD guy. FIT has their own server now not third party, was announced awhile ago. Also read the Barron's Article and all the articles on FIT, they own this market.
Buprenorphine -This drug is intended for use in patients with chronic pain severe enough to require daily, around-the-clock, long-term treatment
The stock is currently trading below that of its peers, despite the robust 3Q15 guidance of about 55 percent year on year growth, increase in margins, as well as future catalysts, such as the GoPro drone, which isexpected to be launched in 1Q16, virtual reality apps being launched and increasing contribution of the company’s media initiatives.
$8 green tomorrow
Ocera Therapeutics Rises on Positive Results
24/7 Wall St. By Chris Lange
For some background: OCR-002 is an ammonia scavenger and has been granted orphan drug designation
and Fast Track status by the U.S. Food and Drug Administration (FDA) for the treatment of hyperammonemia and resultant hepatic encephalopathy in patients with acute liver failure and acute-on-chronic liver disease
CANF Double Dipping
do the DD